NuShield in Surgical Peroneal Tendon Repair



Status:Recruiting
Conditions:Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:18 - 60
Updated:2/27/2019
Start Date:January 30, 2019
End Date:December 2020
Contact:Jimie J Wesson
Email:jwesson@organo.com
Phone:205-329-7275

Use our guide to learn which trials are right for you!

Single Arm Clinical Evaluation of the Safety and Efficacy of the NuShield® Allograft for Peroneal Tendon Repair

The purpose of this study is to evaluate the use of NuShield in subjects requiring surgical
tendon repair.

The objective of this clinical trial is to evaluate both the safety and efficacy of using the
NuShield® allograft in addition to standard of care surgical procedures in subjects requiring
surgical repair of the peroneal tendon. The effects of this treatment will be assessed using:

- Questionnaires

- Visual Analog Scale Foot and Ankle (VAS FA)

- FAAM Sport

- PROMIS Global Health SF

- Tegner Activity Scale

- Foot and Ankle Outcomes Instrument (Q1, Q2)

- Swelling assessments

- Ultrasound imaging for tendon thickness, gliding and adhesion formation

Inclusion Criteria:

- Ages 18 to 60 inclusive

- If female, actively practicing a medically relevant method of contraception,
abstinent, surgically sterile, or post-menopausal (defined as no menses for at least
12 months)

- Have a diagnosis of one of the following in relation to the peroneal tendon:

- Tendonitis with MRI confirmation

- Synovial inflammation

- Tear

- Diagnosis resulting from acute injury to the tendon

Exclusion Criteria:

- BMI equal to or greater than 35

- Prior injury to the peroneal tendon

- Collagen disorders

- Inflammatory arteriopathies

- Immune compromised

- Diabetic

- Less than 6 months between injury and proposed surgery date

- Steroid injection within the past 6 weeks localized to the treatment area

- Pregnant within the past six (6) months, breast feeding and/or desire to become
pregnant during the course of the study, as verified by urine pregnancy test within
one week prior to treatment

- History of more than two (2) weeks treatment with immuno-suppressants, including
systemic corticosteroids or cytotoxic chemotherapy within one month prior to initial
screening, or have received such medications during the screening period, or are
anticipated to require such medications during the course of the study

- Taking any investigational drug(s) or therapeutic device(s) within 30 days preceding
screening

- History of radiation therapy of the affected foot

- Known history of having Acquired Immunodeficiency Syndrome (AIDS) or HIV

- Currently involved in medical litigation, including Worker's Compensation claims of
any type

- Unable to understand the objectives of the trial

- Presence of any condition(s) which, in the opinion of the investigator, would
compromise the subject's ability to complete this study

- Having a known history of poor adherence with medical treatment

- Express an unwillingness to receive human allograft tissue
We found this trial at
2
sites
Birmingham, Alabama 35205
Principal Investigator: Norman Waldrop, M.D.
Phone: 205-327-1077
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials